Investigator Initiated Study to Assess the Efficacy of OC-01 (Varenicline) Nasal Spray on Signs and Symptoms of Dry Eye Disease Following Laser-assisted in Situ Keratomileusis (LASIK)
Condition:   Dry Eye Disease Interventions:   Drug: OC-01 (varenicline 0.6mg/ml) nasal spray;   Drug: Placebo (vehicle) nasal spray Sponsor:   Vance Thompson Vision ND Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - October 19, 2021 Category: Research Source Type: clinical trials

Comparison of Outcomes Between TransPRK and Off-flap Epi-LASIK
Condition:   Refractive Surgery Intervention:   Sponsor:   Wenzhou Medical University Completed (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - September 28, 2021 Category: Research Source Type: clinical trials